SA
PFE icon

Shilanski & Associates’s Pfizer PFE Stock Holding History

Shilanski & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-95,965
Closed -$2.66M – 114
2024
Q1 		$2.66M Buy
95,965
+2,770
+3% +$76.9K 0.92% 37
2023
Q4 		$2.68M Buy
93,195
+751
+0.8% +$22.7K 1.02% 31
2023
Q3 		$3.07M Buy
92,444
+2,908
+3% +$103K 1.25% 29
2023
Q2 		$3.28M Buy
89,536
+2,435
+3% +$94.8K 1.33% 26
2023
Q1 		$3.62M Buy
87,101
+2,154
+3% +$93K 1.63% 24
2022
Q4 		$4.35M Buy
84,947
+77,892
+1,104% +$3.73M 1.9% 13
2022
Q3 		$309K Sell
7,055
-74,057
-91% -$3.6M 0.11% 99
2022
Q2 		$4.25M Buy
81,112
+1,553
+2% +$79.1K 1.99% 14
2022
Q1 		$4.12M Sell
79,559
-1,673
-2% -$86.8K 1.73% 18
2021
Q4 		$4.8M Sell
81,232
-2,298
-3% -$114K 2.04% 13
2021
Q3 		$3.59M Buy
83,530
+2,096
+3% +$92.9K 1.67% 20
2021
Q2 		$3.19M Buy
81,434
+1,996
+3% +$77.6K 1.51% 26
2021
Q1 		$2.88M Sell
79,438
-6,714
-8% -$238K 1.54% 27
2020
Q4 		$3.17M Sell
86,152
-2,885
-3% -$106K 1.93% 16
2020
Q3 		$3.1M Sell
89,037
-60
-0.1% -$2.1K 2.1% 13
2020
Q2 		$2.76M Buy
89,097
+2,509
+3% +$85.2K 2.01% 13
2020
Q1 		$2.68M Buy
86,588
+2,990
+4% +$102K 2.69% 13
2019
Q4 		$3.11M Buy
83,598
+948
+1% +$33.8K 2.39% 17
2019
Q3 		$2.82M Buy
82,650
+2,084
+3% +$75.8K 2.27% 17
2019
Q2 		$3.31M Buy
+80,566
New +$3.2M 2.68% 12

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Shilanski & Associates's PFE Position: Q2 2024 in Review

Shilanski & Associates sold out of Pfizer (PFE) in Q2 2024, closing a stake of 95,965 shares — an estimated $2.66M sold.

Shilanski & Associates first reported a position in PFE in Q2 2019 and held it in 20 quarters. The position peaked at $4.8M in Q4 2021. 2,879 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Shilanski & Associates reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Shilanski & Associates sold 95,965 Pfizer shares in Q2 2024, an estimated $2.66M.
  • Shilanski & Associates first reported a position in Pfizer in Q2 2019 and held it in 20 quarters.
  • Shilanski & Associates's Pfizer position peaked at $4.8M in Q4 2021.
  • 2,879 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Shilanski & Associates's 13F filing for Q2 2024, filed 18 Jul 2024.